A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

מצבים רפואיים

Hepatitis B Virus Infection

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Grifols Investigative site, Chandler, Arizona, United States

    Contact: Study coordinator (Enrikas Vainorius, MD)
  • Grifols Investigative site, Huntington Beach, California, United States

    Contact: Study coordinator (Enrikas Vainorius, MD)
  • Grifols Investigative site, Lake Forest, California, United States

    Contact: Study coordinator (Enrikas Vainorius, MD)
  • Grifols Investigative site, Long Beach, California, United States

    Contact: Study coordinator (Enrikas Vainorius, MD)
  • Grifols Investigative site, Oakland, California, United States

  • Grifols Investigative Site, Peachtree Corners, Georgia, United States

    Contact: Study coordinator (Enrikas Vainorius, MD)
  • Grifols Investigative Site, Iowa City, Iowa, United States

    Contact: Study coordinator (Enrikas Vainorius, MD)
  • Grifols Investigative Site, Lenexa, Kansas, United States

    Contact: Study coordinator (Enrikas Vainorius, MD)
  • Grifols Investigative site, Baltimore, Maryland, United States

    Contact: Study coordinator (Enrikas Vainorius, MD)
  • Grifols Investigative site, San Antonio, Texas, United States

    Contact: Study coordinator (Enrikas Vainorius, MD)
  • Grifols Investigative site, Webster, Texas, United States

    Contact: Study coordinator (Enrikas Vainorius, MD)
  • Grifols Investigative site, Richmond, Virginia, United States

    Contact: Study coordinator (Enrikas Vainorius, MD)
  • Grifols Investigate Site, Concord, New South Wales, Australia

    Contact: Study coordinator (Enrikas Vainorius, MD)
  • Grifols Investigative site, Fortitude Valley, Queensland, Australia

    Contact: Study coordinator (Enrikas Vainorius, MD)
  • Grifols Investigative site, Hong Kong, Hong Kong Island, Hong Kong

    Contact: Study coordinator (Enrikas Vainorius, MD)
  • Grifols Investigative site, Shatin, New Territories, Hong Kong

    Contact: Study coordinator (Enrikas Vainorius, MD)
  • Grifols Investigative site, Seogu, Busan, South Korea

    Contact: Study coordinator (Enrikas Vainorius, MD)
  • Grifols Investigative site, Songpa-dong, Seoul, South Korea

    Contact: Study coordinator (Enrikas Vainorius, MD)
  • Grifols Investigative site, Sanmin, Kaohsiung, Taiwan

    Contact: Study coordinator (Enrikas Vainorius, MD)